Sign in

CIK 0001228627 · Non-accelerated filer<br>Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
113516358
Phone
(984) 884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
  1. D Other Notice of Sales of Unregistered Securities
  2. S-8 Other Securities Offered to Employees in Benefit Plans
  3. EFFECT Other Notice of Effectiveness
  4. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  5. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  6. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  7. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  8. CERT Other Certification
  9. 8-A12B Other Registration of Securities
  10. 25 Other Notification of Removal from Listing
  11. DEFA14A Proxy Proxy Materials
  12. CT ORDER Other Confidential Order
  13. DEFA14A Proxy Proxy Materials
  14. DEFA14A Proxy Proxy Materials
  15. DEFA14A Proxy Proxy Materials
  16. DEFA14A Proxy Proxy Materials
  17. DEFA14A Proxy Proxy Materials
  18. DEFA14A Proxy Proxy Materials
  19. DEFA14A Proxy Proxy Materials
  20. EFFECT Other Notice of Effectiveness

Page 4 of 8 · 148 filings